Detalhe da pesquisa
1.
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586765
2.
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer.
Oncotarget
; 11(22): 2092-2105, 2020 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32547707